Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.

Part of Abbott Laboratories, St. Jude Medical, Atrial Fibrillation Division, Inc. is an American company that manufactures and markets medical devices.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Affera, Inc. manufactures medical devices for cardiac arrhythmia treatment. The firm develops system to treat heart rhythm disorders. The company was founded by Doron Harlev and is headquartered in Watertown, MA.

Biosense Webster, Inc. is the global leader in the science of diagnosing and treating heart rhythm disorders. The company partners with clinicians to develop innovative technologies that improve the quality of care for arrhythmia patients worldwide. Biosense Webster is part of the Johnson & Johnson Family of Companies. More information can be found at www.biosensewebster.com.

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

ReCor Medical has developed a unique therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The PARADISE® technology (Percutaneous Renal Denervation System) includes a 6 French catheter with a cylindrical transducer that emits ultrasound energy circumferentially, allowing for a more efficient renal denervation procedure.

Farapulse, Inc. engages in the development of medical devices. Its products are: Endo Farawave, a percutaneous catheter designed to create transmural and contiguous lesions on the endocardium of the left atrium to isolate the pulmonary veins and EPI Faraone, s designed to create a box lesion around all pulmonary veins from an epicardial placement of the catheter for the treatment of atrial fibrillation. The company was founded by Steven Mickelsen in 2014 and is headquartered in Iowa City, IA.

Auris Surgical Robotics is a company that provides robotic medical care that is transforming medical intervention by introducing the monarch platform. Auris aims to leverage the power of flexible robotics to enable new possibilities in endoscopy, which uses small cameras and tools to enter the body through its natural openings. The Monarch Platform integrates the latest advancements in imaging technology, robotics, endoscope design, sensing, and data science for better outcomes and reduced costs.

VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA.

Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA.

ElectroPhysiology Frontiers makes ablation of atrial fibrillation possible after pulmonary vein isolation. Their catheter design features include radiofrequency and pulse field ablation designs, expandable anchor that stabilises the catheter and improves contact, irrigated cla of electrodes, adjustable distance between anchor and CLA, catheter over the wire design, and visualization with an electro-anatomic mapping system.